December 11, 2023
Selected 2023 projects and workflows (alphabetically ordered): BIOPHTA (Paris, France). US Executive Advisor. BIOPHTA aims to radically change eye treatments for various ophtalmological diseases that require daily eye drops or repeated intraocular injections. BIOPHTA technology of drug delivery improve treatment efficacy by leveraging a micro...
January 3, 2023
[ACTICOR-BIOTECH, Paris, France] US Medical Executive @ Acticor-Biotech ACTISAVE Study – ClinicalTrials.gov Identifier: NCT05070260. Adaptive Efficacy and Safety Study of Glenzocimab Used as an add-on Therapy on Top of Standard of Care un the 4.5 Hours Following an Acute Ischemic Stroke (ACTISAVE) DECOY Therapeutics, Cambridge, MA,...
July 27, 2021
* Utay, N. S., Asmuth, D. M, Gharakhanian, S., Contreras, M., Warner, C. D., & Detzel, C. J. (2021). Potential use of serum-derived bovine immunoglobulin/protein isolate for the management ofCOVID-19. Drug Development Research, 1–7. https://doi.org/10.1002/ddr.21841 * GARDEN (NCT04659109) is a multinational, multicenter, randomized, double-blind,...
January 7, 2021
On 30 December 2019 a ProMed email from the International Society of Infectious Diseases (IDSA) contained information on <Undiagnosed pneumonia in China>, thus alerting the world to what was to become the worst health crisis in 100 years. On 24 January 2020, the New England Journal of Medicine (2020, 382: 727-733) published a brief report from...
September 10, 2020
www.bostonbiotechnologysummit.com The 4th Boston ● Paris Biotechnology Virtual Summit ● Focus on Covid-19 – will be held, via a zoom platform, on Thursday 15 October 2020, 11 AM – 01 PM US EDT [17:00 – 19:00 EU CET] in three sequential panels as below. The Program Committee, listed below*, have convened renowned experts...
July 2, 2020
Dr Shahin Gharakhanian was interviewed on the current Covid-19 pandemic by BIOTECH-FINANCE (issue no.905, Page 7, 29 June 2020), France’s leading Biotechnology business and financial weekly news magazine.Please visit: www.biotech-finances.com
November 8, 2019
For the first time in the US, a joint presentation as an invited speaker (ref. below) @ the forthcoming 5th International Conference on Vaccine Research & Development (Boston/Newton, November 2019). This will focus on the clinical development program being initiated by PAR’IMMUNE [Biotech start-up: CEO Dr A. Lachgar, HQ in Lille, France] that...
June 13, 2019
Click here to download the summit report: PDF Click here to download the summit report: Word
May 29, 2019
Cambridge MA, 30 May 2019 – The 3rd Boston Biotechnology Summit will be held on Sunday, 2 June 2019 at the renowned Wistar Institute in Philadelphia (USA), just before the BIO 2019 Convention. The central theme of this third edition will be collaboration, common foundations, research project development, obtaining regulatory approval and the...
March 19, 2019
Since 2016, we have been diligently building bridges between Boston and European Biotechnologies as a way of accelerating the advent of new treatments in response to patient’s needs, globally. Collaboration is becoming an increasingly important component in the next stage of biotechnology’s evolution. There are at least three fundamental reasons: 1) ...